| Small Business Procurement Advisory Counsel (SBPAC) |
Committee, Work group, Advisory group, or Task Force |
HRSA, CDC, CMS, FDA |
OD/OM, OD/OM/OALM |
Particpate with the Small Business Adminstration and other federal agencies on small business procurement concerns, regulations, and policies. |
| Small Business Program Managers Committee |
Meeting/ Workshop |
CDC, FDA |
OD/DPCPSI/ORIP |
Monthly meetings organized by the Small Business Education and Entrepreneurial Development (SEED) at OER, OD. Attendance includes all Small Business Program Managers of the NIH-ICOs, CDC and FDA. Venue to discuss program updates, presentations , challenges and new initiatives amongst ICOs SB managers. |
| Smallpox Working Group |
Committee, Work group, Advisory group, or Task Force |
ASFR, CDC, FDA |
NIAID |
Working group on smallpox. |
| Smokefree.gov Initiative |
Resource Development |
CDC, FDA, IHS |
NCI |
The Smokefree.gov Initiative (SFGI) provides tobacco users who want to quit with free, evidence-based cessation information and on-demand support. SFGI includes 5 mobile-optimized websites, 10 SMS text programs, a smartphone app, and 6 social media platforms. Tailored content is provided for special populations including women, teens, Spanish speakers, and veterans. |
| Social Determinants of Health Research Coordinating Committee |
Committee, Work group, Advisory group, or Task Force |
SAMHSA |
FIC, NCATS, NCCIH, NCI, NIA, NIAMS, NIEHS, NIMHD, NINR, OD/DPCPSI/OBSSR, OD/DPCPSI/ODP, OD/DPCPSI/ORWH |
The overall goal of the Research Coordinating Committee (RCC) is to accelerate NIH-wide SDOH research across diseases and conditions, populations, stages of the life course, and SDOH domains, domestically and globally. |
| Society for Prevention Research Annual Conference |
Meeting/ Workshop |
ACF, CDC |
NCCIH, NCI, NIAAA, NINR |
This annual conference is funded by an R13 award and is co-funded by several other NIH Institutes as well as the ACF and the CDC. |
| Somatic Cell Genome Editing |
Research Initiative |
FDA |
NCATS, NCI, NEI, NHGRI, NHLBI, NIAID, NIAMS, NIBIB, NICHD, NIDDK, NIEHS, NIMH, NINDS, OD/DPCPSI/ORIP, OD/DPCPSI/OSC |
The Somatic Cell Genome Editing (SCGE) program aims to develop quality tools to perform effective and safe genome editing in human patients. These research tools will be made widely available to the research community to reduce the time and cost required to develop new therapies. Representatives from Food and Drug Administration (FDA) Center for Biologics Evaluation and Research (CBER) attend SCGE Consortium meetings with NIH and Prinicpal Investigators that covers emerging science and opportunities as well as progress of SCGE awardees. The NIH is also establishing a Memorandum of Understanding (MOU) with the FDA for direct NIH/FDA communications on general regulatory issues around genome editing that may inform how NIH manages the SCGE program. The SCGE program is a member of the National Institute of Standards and Technology (NIST) Gene Editing Consortium. |
| Somatic Cell Genome Editing (SCGE)-related Memorandum of Understanding (MOU) |
Other |
FDA |
NCATS, NINDS, OD/DPCPSI/OSC |
The SCGE-related MOU provides the principles and procedures for information sharing between FDA/CBER and NIH. |
| Special Populations Research Forum, Clinical Research Recommendations Subcommittee |
Committee, Work group, Advisory group, or Task Force |
SAMHSA |
NCI, NHLBI, NINDS, OD/DPCPSI/SGMRO |
The Special Populations Research Forum (SPRF) provides a resource for NIH and HHS staff to share best practices and lessons learned in promoting diversity, equity, and inclusion (DEI) in intramural and extramural training and research. |
| State Cancer Profiles |
Resource Development |
CDC |
NCI |
State Cancer Profiles is an interactive mapping engine produced in collaboration between the National Cancer Institute and Centers for Disease Control and Prevention. It was developed with the idea to provide a geographic profile of cancer burden in the United States and reveal geographic disparities in cancer incidence, mortality, risk factors for cancer, and cancer screening across different population subgroups. The target audiences are health planners, policy makers, and cancer information providers who need quick and easy access to cancer related data and maps to inform and prioritize investments in cancer control. Other collaborative activity: database |